US4371520A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for preparing immunoglobulin suitable for intravenous injection
Assignee: Tanabe Pharma Corp
•
Filing: 1981-10-28
•
Granted: 1983-02-01
•
Expires: 2001-10-28
Abstract
Abstract A process for preparing immunoglobulin suitable for intravenous injection, comprising treating with an acid a plasma or fraction I+II+III, fraction II+III, fraction II, or fraction III (hereinafter these are sometimes referred collectively to as starting material) obtained from plasma by Cohn's cold alcohol fractionation method, and subjecting to fractionation using an alkylene oxide polymer or copolymer having a molecular weight of 2,000 to 20,000.
Inventors
- 👤 Yahiro Uemura
- 👤 Takashi Goto
- 👤 Yoshiaki Kano
- 👤 Satoshi Funakoshi
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 01:49
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/06; C07K16/065; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83; Y10S530/831
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
130 words
A process for preparing an immunoglobulin suitable for intravenous injection, which consists essentially of treating a plasma or the Cohn's fraction I+II+III, fraction II+III, fraction II, or fraction III obtained by subjecting a plasma to Cohn's cold alcohol fractionation with an acid at pH 3.2 to 5.0 and at 4° to 15° C. for 30 to 180 minutes, adding to the resulting material at pH 4.6 to 5.4 an alkylene oxide polymer or copolymer having a molecular weight of 2,000 to 20,000 to a concentration of 4.5 to 5.5% (W/V), removing an aggregate-type immunoglobulin as a precipitate, and adding again said polymer or copolymer at pH 8.0 to 9.0 to a concentration of 6 to 13% (W/V) to recover as a precipitate a non-aggregate-type immunoglobulin containing substantially no aggregate-type immunoglobulin.
Claim 2
Dependent Claim
130 words
A process for preparing an immunoglobulin suitable for intravenous injection, which consists essentially of treating a plasma or the Cohn's fraction I+II+III, fraction II+III, fraction II, or fraction III obtained by subjecting a plasma to Cohn's cold alcohol fractionation with an acid at pH 3.2 to 5.0 and at 4° to 15° C. for 30 to 180 minutes, adding to the resulting material at pH 4.6 to 5.4 an alkylene oxide polymer or copolymer having a molecular weight of 2,000 to 20,000 to a concentration of 4.5 to 5.5% (W/V), removing an aggregate-type immunoglobulin as a precipitate, and adding again said polymer or copolymer at pH 8.0 to 9.0 to a concentration of 6 to 13% (W/V) to recover as a precipitate a non-aggregate-type immunoglobulin containing substantially no aggregate-type immunoglobulin.
Claim 3
Dependent Claim
11 words
A process according to claim 1 consisting of the stated steps.
Claim 4
Dependent Claim
154 words
In a process for preparing an immunoglobulin suitable for intravenous injection, which comprises adding to a plasma or the Cohn's fraction I+II+III, fraction II+III, fraction II, or fraction III obtained by subjecting a plasma to Cohn's cold alcohol fractionation at pH 4.6 to 5.4 an alkylene oxide polymer or copolymer having a molecular weight of 2,000 to 20,000 to a concentration of 4.5 to 5.5% (W/V), removing an aggregate-type immunoglobulin as a precipitate, and adding again said polymer or copolymer at pH 8.0 to 9.0 to a concentration of 6 to 13% (W/V) to recover as a precipitate a non-aggregate-type immunoglobulin containing substantially no aggregate-type immunoglobulin, the improvement which comprises treating the plasma or the Cohn's fraction I+II+III, fraction II+III, fraction II, or fraction III with an acid at pH 3.2 to 5.0 and at 4° to 15° C. for 30 to 180 minutes, before the addition of the alkylene oxide polymer or copolymer.
Claim 5
Dependent Claim
154 words
In a process for preparing an immunoglobulin suitable for intravenous injection, which comprises adding to a plasma or the Cohn's fraction I+II+III, fraction II+III, fraction II, or fraction III obtained by subjecting a plasma to Cohn's cold alcohol fractionation at pH 4.6 to 5.4 an alkylene oxide polymer or copolymer having a molecular weight of 2,000 to 20,000 to a concentration of 4.5 to 5.5% (W/V), removing an aggregate-type immunoglobulin as a precipitate, and adding again said polymer or copolymer at pH 8.0 to 9.0 to a concentration of 6 to 13% (W/V) to recover as a precipitate a non-aggregate-type immunoglobulin containing substantially no aggregate-type immunoglobulin, the improvement which comprises treating the plasma or the Cohn's fraction I+II+III, fraction II+III, fraction II, or fraction III with an acid at pH 3.2 to 5.0 and at 4° to 15° C. for 30 to 180 minutes, before the addition of the alkylene oxide polymer or copolymer.
Claim 6
Dependent Claim
19 words
A process according to claim 3, wherein the protein concentration in the acid treatment is 2 to 10% (W/V).
Claim 7
Dependent Claim
19 words
A process according to claim 3, wherein the acid is hydrochloric acid, phosphoric acid, acetic acid, or citric acid.
Claim 8
Dependent Claim
15 words
A process according to claim 3, wherein the plasma is that originated from human blood.
Claim 9
Dependent Claim
20 words
A process according to claim 3, wherein the alkylene oxide polymer is that having methylene, ethylene, propylene or butylene group.
Claim 10
Dependent Claim
15 words
A process according to claim 3, wherein the alkylene oxide copolymer is a polyoxyethylene-polyoxypropylene copolymer.
References Cited (Backward Citations)
US4165370A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-01-31 | 1986-08-02 | 1987-02-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-01-31 | 1990-08-02 | 1991-02-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-01-31 | 1994-08-02 | 1995-02-01 | $7700.00 | Window Closed / Lapsed |